Abstract
Ethanol extract of pawpaw seed was evaluated for a possible application in the management of diabetes. Alloxan was used to induce diabetes in rats, which were subsequently used to study the antihyperglycaemic effect of the extract. Four (4) treatment groups and two (2) control groups of 8 rats each were created using complete randomized design. Triglyceride (TG), total cholesterol (TC), high density lipoprotein (HDL), low-density lipoprotein (LDL), total protein (TP), glutamic oxaloacetic transaminase (SGOT/AST), glutamic pyruvic transaminase (SGPT/ALT), alkaline phosphatase (ALP), urea and creatinine were studied using standard methods. A single dose of alloxan resulted in a significant increase (p < 0.05) in the serum TG, TC, LDL, AST, ALT, ALP, with a corresponding decrease in serum HDL, urea and creatinine. Following treatment with varying doses of the extract, there was a decrease in serum TG, TC, LDL, AST, ALT, ALP, and an increase in serum HDL, urea and creatinine. It could be inferred from the research outcome that crude extract of pawpaw seed (200 mg/kg extract) could be effective in the management of diabetes.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
